Abstract
Fibrous dysplasia is an uncommon metabolic bone disease. Medical management is often not rewarding. Index patient, a 15-year-old girl with history of recurrent fractures on trivial trauma was treated with pamidronate. She showed good outcome with symptomatic improvement and no new fractures over 3 year duration of follow up.
MeSH terms
-
Adolescent
-
Bone Density Conservation Agents / therapeutic use*
-
Diphosphonates / therapeutic use*
-
Female
-
Femoral Neck Fractures / etiology*
-
Femoral Neck Fractures / prevention & control
-
Fibrous Dysplasia, Polyostotic / complications
-
Fibrous Dysplasia, Polyostotic / diagnosis
-
Fibrous Dysplasia, Polyostotic / drug therapy*
-
Humans
-
Pamidronate
Substances
-
Bone Density Conservation Agents
-
Diphosphonates
-
Pamidronate